# Study to Evaluate the Influence of Tegoprazan on the Pharmacokinetics of Proguanil in Healthy Volunteers

> **NCT04568772** · PHASE1 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 19 (actual)

## Conditions studied

- Gastroesophageal Reflux Disease

## Interventions

- **DRUG:** Atovaquone / Proguanil 250/100 mg
- **DRUG:** Tegoprazan 50 mg
- **DRUG:** Esomeprazole 40 mg
- **DRUG:** Vonoprazan 20 mg

## Key facts

- **NCT ID:** NCT04568772
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-25
- **Primary completion:** 2021-07-08
- **Final completion:** 2021-08-03
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2021-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04568772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04568772, "Study to Evaluate the Influence of Tegoprazan on the Pharmacokinetics of Proguanil in Healthy Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04568772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*